Tumour necrosis factor-α and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 5, 2011, Pages 300-306

  Kong, Shan Shan ^a   Liu, Jin Jun ^a   Hwang, Tyzh Chang ^b   Yu, Xiao Jiang ^a   Lu, Yi ^a   Zang, Wei Jin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

Acute myocardial infarction; Cardiac function; Tumour necrosis factor ; Vagus nerve

Indexed keywords

CREATINE KINASE; LACTATE DEHYDROGENASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEMODYNAMICS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; VAGUS NERVE STIMULATION; WESTERN BLOTTING;

ANIMALS; CREATINE KINASE; GENE EXPRESSION REGULATION; HEMODYNAMICS; L-LACTATE DEHYDROGENASE; MALE; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VAGUS NERVE STIMULATION; VENTRICULAR REMODELING;

EID: 79955389278     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05505.x     Document Type: Article

References (48)

1. Ono K, Matsumori A, Shioi T, Furukawa Y, Sasayama S. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling. Circulation 1998; 98: 149-56.
2. Frangogiannis NG. Targeting the inflammatory response in healing myocardial infarcts. Curr. Med. Chem. 2006; 13: 1877-93.
3. Shames BD, Barton HH, Reznikov LL et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium. Shock 2002; 17: 114-9.
4. Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J. Card. Fail. 1997; 3: 117-24.
5. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N. Engl. J. Med. 1990; 323: 236-41.
6. Sigusch HH, Lehmann MH, Schnittler U, Reinhardt D, Figulla HR. Tumour necrosis factor-alpha expression in idiopathic dilated cardiomyopathy: Correlation to myocardial inflammatory activity. Cytokine 2000; 12: 1261-6.
7. Kurrelmeyer KM, Michael LH, Baumgarten G et al. Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction. Proc. Natl Acad. Sci. USA 2000; 97: 5456-61.
8. Janczewski AM, Kadokami T, Lemster B, Frye CS, McTiernan CF, Feldman AM. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. Am. J. Physiol. Heart Circ. Physiol. 2003; 284: H960-9.
9. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J. Clin. Invest. 1993; 92: 2303-12.
10. Balligand JL, Ungureanu D, Kelly RA et al. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J. Clin. Invest. 1993; 91: 2314-9.
11. Guggilam A, Haque M, Kerut EK et al. TNF-alpha blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats. Am. J. Physiol. Heart Circ. Physiol. 2007; 293: H599-609.
12. Tang Z, McGowan BS, Huber SA et al. Gene expression profiling during the transition to failure in TNF-alpha over-expressing mice demonstrates the development of autoimmune myocarditis. J. Mol. Cell. Cardiol. 2004; 36: 515-30.
13. 2+ transients. FEBS Lett. 1995; 376: 24-30.
14. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92: 1487-93.
15. Monden Y, Kubota T, Inoue T et al. Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 2007; 293: H743-53.
16. Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
17. Bernik TR, Friedman SG, Ochani M et al. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J. Vasc. Surg. 2002; 36: 1231-6.
18. Altavilla D, Guarini S, Bitto A et al. Activation of the cholinergic anti-inflammatory pathway reduces NF-kappab activation, blunts TNF-alpha production, and protects againts splanchic artery occlusion shock. Shock 2006; 25: 500-6.
19. Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ. Res. 2009; 104: E9-18.
20. Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. J. Card. Fail. 2007; 13: 588-96.
21. Daosukho C, Chen Y, Noel T et al. Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury. Free Radic. Biol. Med. 2007; 42: 1818-25.
22. Ay I, Lu J, Ay H, Gregory SA. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia. Neurosci. Lett. 2009; 459: 147-51.
23. Rajesh KG, Sasaguri S, Zhitian Z, Suzuki R, Asakai R, Maeda H. Second window of ischemic preconditioning regulates mitochondrial permeability transition pore by enhancing Bcl-2 expression. Cardiovasc. Res. 2003; 59: 297-307.
24. Patten RD, Aronovitz MJ, Einstein M et al. Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse. Clin. Sci. 2003; 104: 109-18.
25. 2 promotes striated muscle growth. Nat. Med. 2003; 9: 944-51.
26. Fahim MR, Halim SM, Kamel I. Tumor necrosis factor alpha in patients with acute myocardial infarction. Egypt. J. Immunol. 2004; 11: 31-7.
27. Biswas S, Ghoshal PK, Mandal SC, Mandal N. Relation of anti- to pro-inflammatory cytokine ratios with acute myocardial infarction. Korean J. Intern. Med. 2010; 25: 44-50.
28. Sroka K. On the genesis of myocardial ischemia. Z. Kardiol. 2004; 93: 768-83.
29. Jardine DL, Charles CJ, Ashton RK et al. Increased cardiac sympathetic nerve activity following acute myocardial infarction in a sheep model. J. Physiol. 2005; 565: 325-33.
30. Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD, Poole-Wilson PA. Autonomic imbalance and immune activation in chronic heart failure: Pathophysiological links. Cardiovasc. Res. 2006; 70: 434-45.
31. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunagawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109: 120-4.
32. Schwartz PJ, De Ferrari GM, Sanzo A et al. Long term vagal stimulation in patients with advanced heart failure: First experience in man. Eur. J. Heart Fail. 2008; 10: 884-91.
33. Sammel NL, Norris RM, Hughes CF, Johnson RN, Ashton NG, Elliott RL. Severity of canine myocardial infarcts in relation to indices of oxygen demand: Preservation of myocardial creatine kinase activity by vagal stimulation and propranolol. Cardiovasc. Res. 1983; 17: 50-60.
34. Feliciano L, Henning RJ. Vagal nerve stimulation releases vasoactive intestinal peptide which significantly increases coronary artery blood flow. Cardiovasc. Res. 1998; 40: 45-55.
35. Ando M, Katare RG, Kakinuma Y et al. Efferent vagal nerve stimulation protects heart against ischemia-induced arrhythmias by preserving connexin43 protein. Circulation 2005; 112: 164-70.
36. Tsutsumi T, Ide T, Yamato M et al. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction. Cardiovasc. Res. 2008; 77: 713-21.
37. Uemura K, Zheng C, Li M, Kawada T, Sugimachi M. Early short-term vagal nerve stimulation attenuates cardiac remodeling after reperfused myocardial infarction. J. Card. Fail. 2010; 16: 689-99.
38. Katare RG, Ando M, Kakinuma Y et al. Vagal nerve stimulation prevents reperfusion injury through inhibition of opening of mitochondrial permeability transition pore independent of the bradycardiac effect. J. Thorac. Cardiovasc. Surg. 2009; 137: 223-31.
39. Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
40. Mariappan N, Elks CM, Fink B, Francis J. TNF-induced mitochondrial damage: A link between mitochondrial complex I activity and left ventricular dysfunction. Free Radic. Biol. Med. 2009; 46: 462-70.
41. Liakopoulos OJ, Teucher N, Muhlfeld C et al. Prevention of TNFalpha-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment. Eur. J. Cardiothorac. Surg. 2006; 30: 263-70.
42. Irwin MW, Mak S, Mann DL et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 1999; 99: 1492-8.
43. Jacobs M, Staufenberger S, Gergs U et al. Tumor necrosis factor-alpha at acute myocardial infarction in rats and effects on cardiac fibroblasts. J. Mol. Cell. Cardiol. 1999; 31: 1949-59.
44. Francis J, Chu Y, Johnson AK, Weiss RM, Felder RB. Acute myocardial infarction induces hypothalamic cytokine synthesis. Am. J. Physiol. Heart Circ. Physiol. 2004; 286: H2264-71.
45. Li DL, Liu JJ, Liu BH et al. Acetylcholine inhibits hypoxia-induced tumor necrosis factor-alpha production via regulation of MAPKs phosphorylation in cardiomyocytes. J. Cell. Physiol. 2011; 226: 1052-9.
46. Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc. Res. 2004; 61: 481-97.
47. Ramani R, Mathier M, Wang P et al. Inhibition of tumor necrosis factor receptor-1-mediated pathways has beneficial effects in a murine model of postischemic remodeling. Am. J. Physiol. Heart Circ. Physiol. 2004; 287: H1369-77.
48. Van de Werf F, Ardissino D, Betriu A et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The task force on the management of acute myocardial infarction of the European society of cardiology. Eur. Heart J. 2003; 24: 28-66.